So having just needed agreement on the endpoints do we think Neuren has now submitted the final trial protocol for review and we're just waiting on an FDA response? Or does the company still need to compile and file that first? More out of interest really as they've once more stated they're on track for a mid year Ph3 start but nice to know the details if anyone is confident of the situation??
Ann: NEU receives FDA minutes and re-confirms Phase 3 endpoints, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.10 |
Change
-0.800(5.76%) |
Mkt cap ! $1.629B | |||
| Open | High | Low | Value | Volume |
| $13.95 | $13.96 | $12.88 | $9.534M | 725.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 266 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.15 | 1619 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |